Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARGARET M EBERL

Allopathic & Osteopathic Physicians Family Medicine

NPI
1669466843
CMS profile
524599
Location
BUFFALO, NY

General Payments · PY2018–2023

$1,066.90

  • Reported across 28 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$256.19

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $256.19 15

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
ACADIA Pharmaceuticals Inc $232.88 14
Lilly USA, LLC $23.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $89.56 3
PY2019 $122.17 2
PY2020 $117.81 1
PY2021 $208.19 3
PY2022 $272.98 4
PY2023 $256.19 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ACADIA Pharmaceuticals Inc $8.16 01/13/2023 Food and Beverage Undisputed 01/23/2026 1053127965 CMS
ACADIA Pharmaceuticals Inc $24.68 01/19/2023 Food and Beverage Undisputed 01/23/2026 1053127969 CMS
ACADIA Pharmaceuticals Inc $4.33 03/31/2023 Food and Beverage Undisputed 01/23/2026 1053127973 CMS
ACADIA Pharmaceuticals Inc $1.90 03/31/2023 Food and Beverage Undisputed 01/23/2026 1053127977 CMS
ACADIA Pharmaceuticals Inc $4.75 04/18/2023 Food and Beverage Undisputed 01/23/2026 1053127981 CMS
ACADIA Pharmaceuticals Inc $3.25 06/30/2023 Food and Beverage Undisputed 01/23/2026 1053127985 CMS
ACADIA Pharmaceuticals Inc $1.08 06/30/2023 Food and Beverage Undisputed 01/23/2026 1053127989 CMS
ACADIA Pharmaceuticals Inc $2.60 07/07/2023 Food and Beverage Undisputed 01/23/2026 1053127993 CMS
ACADIA Pharmaceuticals Inc $2.75 07/07/2023 Food and Beverage Undisputed 01/23/2026 1053127997 CMS
ACADIA Pharmaceuticals Inc $77.45 07/21/2023 Food and Beverage Undisputed 01/23/2026 1053128001 CMS
ACADIA Pharmaceuticals Inc $77.45 07/21/2023 Food and Beverage Undisputed 01/23/2026 1053128005 CMS
ACADIA Pharmaceuticals Inc $0.60 08/17/2023 Food and Beverage Undisputed 01/23/2026 1053128009 CMS
ACADIA Pharmaceuticals Inc $2.33 08/17/2023 Food and Beverage Undisputed 01/23/2026 1053128013 CMS
ACADIA Pharmaceuticals Inc $21.55 09/11/2023 Food and Beverage Undisputed 01/23/2026 1053128017 CMS
Lilly USA, LLC $23.31 04/20/2023 Food and Beverage Undisputed 01/23/2026 1031791537 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.